Table 3.

The significant variants (with a p-value of minus four orders of magnitude or better) for different analysis on our data. The last column (additional association) gives information about more associations for the variant in our data or citations for that variant in other GWAS studies (PMIDs are provided). OR is odds ratio.

SNV BP	Rs Id	Gene	p-Value	OR	Additional Association
Cancer (rPDAC + nrPC) vs. CP:
8:143561151	rs12541790	GSDMD	$1.54\times {10}^{-5}$	3.26	In particular, with nrPC
20:49633437	rs11471493	B4GALT5	$5.11\times {10}^{-5}$	2.60	rPDAC & CA19 False Negative (p-value = $2.81\times {10}^{-4}$)
8:143562235	rs11551198	GSDMD	$5.21\times {10}^{-5}$	0.31
20:49634210	rs235032	B4GALT5	$1.37\times {10}^{-4}$	2.17	rPDAC & CA19 False Negative (p-value = $1.44\times {10}^{-4}$)
16:3067936	rs2239303	IL32	$1.91\times {10}^{-4}$	0.43	Another GWAS study with acute lung, PMID: 21649914
4:128039414	rs11098945	ABHD18	$3.72\times {10}^{-4}$	0.47	Other GWAS studies with type 2 diabetes,
					PMIDs: 26964836, 25774817, 25145545, 24843659 & 21490949
11:61127379	rs375347163	CD5	$4.04\times {10}^{-4}$	0.35
11:61127380	rs72912997	CD5	$4.04\times {10}^{-4}$	0.35
6:70579486	rs1048886	SDHAF4	$6.16\times {10}^{-4}$	0.43	Other GWAS studies with type 2 diabetes,
					PMIDs: 26964836, 25774817, 25145545, 24843659 & 21490949
14:99169513	rs375191905	BCL11B	$7.27\times {10}^{-4}$	0.36
rPDAC vs. CP
12:9083754	rs1385820032	A2M	$5.59\times {10}^{-5}$	0.22
16:3067936	rs2239303	IL32	$7.04\times {10}^{-5}$	0.34
8:23188960	rs1334003684	RP11-1149O23.2	$8.37\times {10}^{-5}$	0.24
15:61856531	15:61856531	RP11-16B9.1	$8.80\times {10}^{-5}$	0.3
14:99169513	rs375191905	BCL11B	$1.38\times {10}^{-4}$	0.23
20:49633437	rs1555810424	B4GALT5	$2.11\times {10}^{-4}$	2.86	CA19 False Negative (p-value = $1.2\times {10}^{-4}$)
20:49634210	rs235032	B4GALT5	$2.24\times {10}^{-4}$	2.49	CA19 False Negative (p-value = $1.2\times {10}^{-4}$)
3:64000218	rs112759850	PSMD6-AS2	$2.94\times {10}^{-4}$	0.11
12:107733077	rs1045749	PRDM4	$4.45\times {10}^{-4}$	0.42
3:70957989	rs1387507994	FOXP1	$4.48\times {10}^{-4}$	0.27
13:52413342	rs13431	VPS36	$6.70\times {10}^{-4}$	2.36	Another GWAS study with Ulcerative colitis, PMID: 27902482
12:107733387	12:107733387	PRDM4	$8.41\times {10}^{-4}$	0.43
12:115821	rs66898998	MED13L	$9.33\times {10}^{-4}$	0.43
17:42315197	rs368910594	STAT3	$9.54\times {10}^{-4}$	0.33
17:50862895	17:50862895	TOB1	$9.86\times {10}^{-4}$	0.13
4:128039414	rs11098945	ABHD18	$9.92\times {10}^{-4}$	0.43
nrPC vs. CP
8:143561151	rs12541790	GSDMD	$8.93\times {10}^{-5}$	3.541
8:133458886	rs879077709	ST3GAL1	$9.08\times {10}^{-5}$	0.21
8:143562235	rs11551198	GSDMD	$1.50\times {10}^{-4}$	0.26
2:74969604	rs7881	POLE4	$2.11\times {10}^{-4}$	0.347
2:96834655	rs10643982	CNNM3	$2.71\times {10}^{-4}$	0.33
6:70579486	rs1048886	SDHAF4	$3.72\times {10}^{-4}$	0.3
8:17229247	rs1043093	CNOT7	$7.59\times {10}^{-4}$	0.12
17:1736164	rs11549259	WDR81	$9.30\times {10}^{-4}$	0.41
rPDAC vs. nrPC
12:131922463	rs3088051	ULK1	$6.31\times {10}^{-5}$	0.34	Another GWAS study with Crohn’s disease, PMID: 22536218
12:27755670	rs3751233	MRPS35	$7.91\times {10}^{-4}$	0.30
11:112084759	rs544184	C11orf57	$8.01\times {10}^{-4}$	2.17	Another GWAS study with colorectal cancer, PMID: 26377099